Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations
about
Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia.VPREB1 deletions occur independent of lambda light chain rearrangement in childhood acute lymphoblastic leukemia.Host genetic variants of ABCB1 and IL15 influence treatment outcome in paediatric acute lymphoblastic leukaemia.Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directions.Ikaros and leukaemia.Genomics in acute lymphoblastic leukaemia: insights and treatment implications.Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia.Prognostic significance of cytokine receptor-like factor 2 alterations in acute lymphoblastic leukemia: a meta-analysis.Hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia and Down syndrome.An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions.Blinatumomab activity in a patient with Down syndrome B-precursor acute lymphoblastic leukemia.Gene alterations involving the CRLF2-JAK pathway and recurrent gene deletions in Down syndrome-associated acute lymphoblastic leukemia in Japan.Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.Impact of therapy in a cohort of unselected children with Down Syndrome-associated Acute Lymphoblastic Leukaemia
P2860
Q33578333-01915594-E924-4D18-B79F-6A14B3C1C093Q33705933-E1E7DA18-55BF-493D-BF48-72C463DF6984Q37650740-D997788C-CB2B-4973-A785-1B644B0AF9B9Q38097334-9F1B1660-92BE-4036-9B23-73443963E8D4Q38371003-A6555B2A-FF49-443B-930B-2E5BD76CD1CCQ38381463-B4ACEBCD-63B6-445D-9E3E-844CCE88270FQ41000106-3124631C-4DD5-4BBE-B643-B37D429E1EEAQ41003977-78A4A732-8C8E-49CF-9979-F9E10F7A6275Q41724174-B4680072-E9E6-4C52-B338-983F614C2831Q43922213-AFB4C904-37E6-475E-861C-F2D5264FDCEBQ47786126-A9A935C7-1992-4E8E-A58A-E1FD3F8A4AF1Q54336349-42EE5D99-8773-451F-9978-EC6DCB2B182FQ54482212-58995385-32BB-46B9-B025-635E984DF2EDQ58317408-E1975729-0D3A-4DC2-B46C-A940A8EE4705
P2860
Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations
description
im März 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 22 March 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2012
@uk
name
Outcome in children with Down' ...... eletions and CRLF2 aberrations
@en
Outcome in children with Down' ...... eletions and CRLF2 aberrations
@nl
type
label
Outcome in children with Down' ...... eletions and CRLF2 aberrations
@en
Outcome in children with Down' ...... eletions and CRLF2 aberrations
@nl
prefLabel
Outcome in children with Down' ...... eletions and CRLF2 aberrations
@en
Outcome in children with Down' ...... eletions and CRLF2 aberrations
@nl
P2093
P2860
P50
P356
P1433
P1476
Outcome in children with Down' ...... eletions and CRLF2 aberrations
@en
P2093
A van der Veer
C D Mitchell
H B Beverloo
L J Russell
M L den Boer
M M van den Heuvel-Eibrink
M Zimmermann
P2860
P2888
P304
P356
10.1038/LEU.2012.84
P577
2012-03-22T00:00:00Z